Evidence map›Paper›PMID 31149463›Full record

ArticleInternational cancer conference journal2017

Successful treatment by prednisolone for interstitial pneumonia associated with anagrelide in a patient with essential thrombocythemia.

Satoshi Tamaru, Yasutaka Tono, Takeshi Matsumoto, Hiroyasu Oda, Yuka Sugimoto, Toshiro Mizuno, Naoyuki Katayama, Masakatsu Nishikawa

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Satoshi Tamaru1Department of Hematology and Oncology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie, 514-8507 Japan.ORCID 0000-0002-2959-6077
Yasutaka Tono1Department of Hematology and Oncology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie, 514-8507 Japan.
Takeshi Matsumoto1Department of Hematology and Oncology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie, 514-8507 Japan.
Hiroyasu Oda1Department of Hematology and Oncology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie, 514-8507 Japan.
Yuka Sugimoto1Department of Hematology and Oncology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie, 514-8507 Japan.
Toshiro Mizuno1Department of Hematology and Oncology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie, 514-8507 Japan.
Naoyuki Katayama1Department of Hematology and Oncology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie, 514-8507 Japan.
Masakatsu Nishikawa1Department of Hematology and Oncology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie, 514-8507 Japan.
Mie University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anagrelide is a cytoreductive agent for essential thrombocythemia and its common side effects are anemia, headache, palpitation, diarrhea, and fluid retention. However, severe pulmonary adverse effects are rare. A 66-year-old Japanese man with essential thrombocythemia presented with hemoptysis 2 months after starting anagrelide treatment. Interstitial pneumonia was diagnosed based on physical and radiographic findings. Discontinuation of anagrelide and institution of corticosteroids resulted in the improvement of interstitial pneumonia. Severe lung injury associated with anagrelide is a rare but an important adverse event that must be addressed when treating interstitial pneumonia.

Indexed as

AnagrelideCorticosteroidsEssential thrombocythemiaHypersensitivity pneumonitisInterstitial pneumonia

Identifiers

PMID31149463
PMCPMC6498308
OpenAlexW2524124549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.